PragmaClin Research Inc.
PrivateLast Round
Grant
Oct 15, 2025
Est. Valuation
$4M
Total Funding Raised
$421,500
Company Overview
PragmaClin Research Inc. operates in Healthcare & Life Sciences and is based in St. John's, Newfoundland and Labrador. Its latest recorded funding round was a Grant round in October 2025.
PragmaClin Research Inc. is a health-tech company developing a digital platform for the assessment and management of neurological disorders such as Parkinson's Disease.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Devices, Healthcare Analytics, Telemedicine, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PragmaClin Research Inc. Comparables
Compare PragmaClin Research Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Machine Medicine Technologies | 83% | |
| Rune Labs | 82% | |
| Great Lakes NeuroTechnologies Inc. | 78% |
For institutional investors. Book with your work email.
PragmaClin Research Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Grant | Jun 18, 2024 | ||||
| Seed | Oct 1, 2023 | ||||
| Grant | Feb 27, 2023 | ||||
| Grant | May 1, 2022 | ||||
Grant | Mar 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PragmaClin Research Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation and Business Investment Corporation | Grant |
| Memorial Centre for Entrepreneurship | Grant |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Washington University in St. Louis | Grant |
| Centre for Aging and Brain Health Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Grew 50% QoQ, from 8 to 12 employees.
- Jun 18, 2024
$150K grant received from Centre for Aging and Brain Health Innovation.
For institutional investors. Book with your work email.
PragmaClin Research Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PragmaClin Research Inc.'s valuation, stock price, and market status.
Is PragmaClin Research Inc. a public or private company?
PragmaClin Research Inc. is a private company.
What is the current stock price of PragmaClin Research Inc.?
PragmaClin Research Inc. is a private company, so its shares have no public market price. Caplight tracks PragmaClin Research Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PragmaClin Research Inc. worth (valuation)?
PragmaClin Research Inc.'s valuation is estimated at $4.0M based on funding round data.
Can I buy PragmaClin Research Inc. stock?
PragmaClin Research Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PragmaClin Research Inc.'s last funding round?
PragmaClin Research Inc.'s most recent funding round was Grant on October 15, 2025.
Who are the main investors in PragmaClin Research Inc.?
Key investors in PragmaClin Research Inc. include Innovation and Business Investment Corporation.
Will PragmaClin Research Inc. IPO soon?
No public IPO plans have been announced for PragmaClin Research Inc..
How can I track PragmaClin Research Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PragmaClin Research Inc.'s shares on secondary markets.